4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-034627
Director sold 22,086 shares at $11.18 ($247,008)
- Director disposed of 400,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Canaan IX L.P. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-29 | Sale : show line 1 in the form | −22,086 | $11.18 | $247,008 | 3,644,381 | I |
| 2016-11-30 | Other disposition : show line 2 in the form | −400,000 | 3,244,381 | I | ||
| Open-market sales · 22,086 sh · avg $11.18 · $247,008 | ||||||
Loading xslF345X03/doc4.xml…